Live Breaking News & Updates on Ancer Hepatocellular

Stay updated with breaking news from Ancer hepatocellular . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New Trials in GI Cancers: Could Your Patient Benefit?

Maybe one of your patients can join a new clinical trial in noncolorectal gastrointestinal cancer? ....

Winston Salem , North Carolina , United States , New Jersey , New York , Santa Monica , District Of Columbia , Rhode Island , South Korea , Richard Goldberg , National Cancer Institute , Virginia University Cancer Institute , Wake Forest Baptist Comprehensive Cancer Center , West Virginia University Cancer Institute , Biliary Cholangitis , Cymabay Therapeutics , Unresectable Locally Advanced , Metastatic Hepatocellular , Monica Hematology Oncology , Noncolorectal Gastrointestinal Cancer , Oncolorectal Gi Cancer , Biologic Therapy , Hepatocellular Carcinoma , Liver Cancer , Hepatocellular Cancer , Ancer Liver ,

Low-Dose Aspirin Reduces Liver Fat, Inflammation Markers

A single daily low dose of aspirin significantly reduced hepatic fat fraction and liver transaminase levels in a randomized trial in patients with metabolic-associated steatotic liver disease. ....

United States , Marye Mccarthy Rinella , Mark Hartman , Robertm Wilechansky , Significant Weight Gain In Placebo Group , Eli Lilly Co , Drug Administration , University Of Chicago Pritzker School Medicine , Massachusetts General Hospital , Liver Meeting , American Association , Liver Diseases , Medscape Medical , Eli Lilly , Weight Gain , Placebo Group , Carthy Rinella , Chicago Pritzker School , Nonalcoholic Fatty Liver Disease , Biliary Disease , Allbladder Disease , Hepatocellular Carcinoma , Liver Cancer , Hepatocellular Cancer , Ancer Liver , Ancer Hepatocellular ,

Fewer Than 1 in 4 Patients With HCV-Related HCC Get DAAs

Early uncertainty about the safety of noninterferon antivirals in patients with liver cancer may have contributed to the slow acceptance of direct-acting antiviral agents in this population. ....

University Of California San Francisco , United States , Palo Alto , Stanford University , Steven Bollipo , Leslie Yeeman Kam , Comoderator Jennifer , Stanford University Medical Center , Liver Meeting , American Association , Liver Diseases , Clinformatics Data Mart , John Hunter Hospital , New South Wales , Medscape Medical , California San Francisco , Hepatitis C , Cv Hepatitisc Virus , Hepatocellular Carcinoma , Liver Cancer , Hepatocellular Cancer , Ancer Liver , Ancer Hepatocellular , Viral Hepatitis , Liver Disease , Alignant Neoplasia ,

New Insights Into How Omega-3 Fatty Acids Improve NASH

Omega-3 fatty acids downregulate expression of betacellulin in patients with NASH, providing a potential new avenue for prevention and treatment, a study has found. ....

Jyothi Padiadpu , Us Department Of Agriculture , Oregon State University College Of Pharmacy , National Institute Of Diabetes , Oregon State University College , National Institute , Digestive Kidney Diseases , Nonalcoholic Fatty Liver Disease , Hepatocellular Carcinoma , Liver Cancer , Hepatocellular Cancer , Ancer Liver , Ancer Hepatocellular , Fatty Acids , Biliary Disease , Allbladder Disease , Alignant Neoplasia , Liver Fibrosis , Cancer Risk , Nonalcoholic Steatohepatitis , Ash Nonalcoholic Steatohepatitis ,

MASLD, MASH Projected to Grow by 23% in the US Through 2050

A mathematical model forecasts a steady increase in liver disease burden, including a near doubling of liver cancers and a more than twofold increase in liver transplants. ....

United States , Norah Terrault , Phuc Le , Cleveland Clinic Lerner College Of Medicine , Cleveland Clinic Lerner College , Liver Meeting , American Association , Liver Diseases , Liver Disease , Nonalcoholic Fatty Liver Disease , Hepatocellular Carcinoma , Liver Cancer , Hepatocellular Cancer , Ancer Liver , Ancer Hepatocellular , Biliary Disease , Allbladder Disease , Metabolic Syndrome , Alignant Neoplasia ,